secwatch.observer — SEC 8-K summary
======================================

Issuer:     PETMED EXPRESS INC (PETS)
CIK:        0001040130
Form:       8-K
Filed at:   2026-09-21T12:35:27+00:00
Accession:  0001040130-26-000047
Event type: leadership
Sentiment:  positive
Materiality: 0.25
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PetMed Express appoints Tamar Elkeles as independent director, board expands to 5
--------------------------------------------------------------------------------

- Tamar Elkeles, PhD appointed independent director effective Sept 17, 2026; board expands from 4 to 5 members.
- Will serve on Compensation & Human Capital and Governance & Nominating Committees; press release names her Chair of Compensation & Human Capital.
- Over 30 yrs experience; ex-Chief Learning & Talent Officer at Qualcomm (1992-2015), scaling revenue from $100M to $25B.
- Compensation under Non-Employee Director Compensation Program; standard indemnification agreement to be entered.
- Appointment follows recent executive leadership transition; Jeff Willard named CEO and President.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1040130/000104013026000047/0001040130-26-000047-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1040130/000104013026000047/pets-20260915.htm
  HTML page:      https://secwatch.observer/filing/0001040130-26-000047

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer